Back
Genmab A/S Quote, Financials, Valuation and Earnings
MarketBeat Alert: Strong sell signal just issued for these 20 stocks
Go here now to get free instant access to all 20 stocks to sell.
Sell
34
GNMSF
Genmab A/S
Last Price:
272.81
Seasonality Move:
12.96%
7 Day Trial
ALL ACCESS PASS
$
7
DeFi Coin Triggers All "Buy" Signals And Could Break Out Soon
Discover our top DeFi pick for potentially massive gains now (before it's too late).Genmab A/S Price Quote
$272.81
-1.41 (-0.51%)
(Updated: May 1, 2024 at 6:55 PM ET)
Genmab A/S Key Stats
Sell
34
Genmab A/S (GNMSF)
is a Sell
Day range:
$274.22 - $284.63
52-week range:
$262.00 - $426.50
Dividend yield:
0%
P/E ratio:
28.61
P/S ratio:
7.56
P/B ratio:
3.81%
Volume:
120
Avg. volume:
593
1-year change:
-32.9%
Market cap:
$17.9B
Revenue:
$2.4B
EPS:
$9.62
How Much Does Genmab A/S Make?
-
How Much Are Genmab A/S's Sales Annually?
GNMSF Revenues are $2.4B -
How Much Profit Does Genmab A/S's Make A Year?
GNMSF net income is $631.9M
Is Genmab A/S Growing As A Company?
-
What Is Genmab A/S's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.04% -
What Is Genmab A/S's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0.31%
Genmab A/S Stock Price Performance
-
Did Genmab A/S Stock Go Up Last Month?
Genmab A/S share price went down by -10.56% last month -
Did GNMSF's Share Price Rise Over The Last Year?
GNMSF share price fell by -32.9% over the past 1 year
What Is Genmab A/S 52-Week High & Low?
-
What Is Genmab A/S’s 52-Week High Share Price?
Genmab A/S has traded as high as $426.50 over the past 52 weeks -
What Is Genmab A/S’s 52-Week Low Share Price?
Genmab A/S has traded as low as $262.00 over the past 52 weeks
Genmab A/S Price To Free Cash Flow
-
Is Genmab A/S Stock Overvalued?
Genmab A/S is trading at a price to free cash flow ratio of 17.78 -
Is Genmab A/S Stock Undervalued?
Genmab A/S EV to Free Cash Flow ratio is 13.49 -
What Is Genmab A/S’s Price Earnings Growth Ratio?
GNMSF PEG ratio is 0.00 -
Is Genmab A/S Trading At A Premium To Earnings?
Genmab A/S EV to EBIT ratio is 16.62
Is It Risky To Buy Genmab A/S?
-
How Much Debt Does Genmab A/S Have?
Total long term debt quarterly is $0 -
How Much Cash Does Genmab A/S Have?
Cash and short term investments quarterly total is $4.2B -
What Is Genmab A/S’s Book Value Per Share?
Book value per share is 71.84
Is Genmab A/S Cash Flow Positive?
-
What Is GNMSF Cash Flow From Operations?
Cash flow from operations (TTM) is $1.1B -
What Is Genmab A/S’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$88M -
What Is Genmab A/S’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$186.1M
Genmab A/S Return On Invested Capital
-
Is Management Doing A Good Job?
GNMSF return on invested capital is 14.96% -
What Is Genmab A/S Return On Assets?
ROA measures how assets are converting to revenues and is 13.39% -
What Is GNMSF Return On Equity?
ROE is a measure of profitability and is 14.96%
Genmab A/S Earnings Date & Stock Price
-
What Is Genmab A/S's Stock Price Today?
A single share of GNMSF can be purchased today for 274.22 -
What Is Genmab A/S’s Stock Symbol?
Genmab A/S trades on the otcm under the ticker symbol: GNMSF -
When Is Genmab A/S’s Next Earnings Date?
The next quarterly earnings date for Genmab A/S is scheduled on May 2, 2024 -
When Is GNMSF's next ex-dividend date?
Genmab A/S's next ex-dividend date is May 26, 2020 -
How To Buy Genmab A/S Stock?
You can buy Genmab A/S shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Genmab A/S Competitors
-
Who Are Genmab A/S's Competitors?
Below is a list of companies who compete with Genmab A/S or are related in some way:
Genmab A/S Dividend Yield
Data Unavailable
Genmab A/S Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 30.82% | 0% |
| Revenue: | -4.4% | 0.65% |
Analyst Recommendations
| Buy Recommendations: | 0 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 0.00 |
| Downside from Last Price: | -100% |